Cocaine cross-sensitization to dopamine uptake inhibitors: Unique effects of GBR12909

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 4, 1996, Pages 911-918

  Elmer, G I ^a   Brockington, A ^a   Gorelick, D A ^a   Carrol, F I ^a   Rice, K C ^a   Matecka, D ^a   Goldberg, S R ^a   Rothman, R B ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cocaine; GBR12909; Mazindol; RTI 55; Sensitization

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE; DOPAMINE UPTAKE INHIBITOR; MAZINDOL; PSYCHOSTIMULANT AGENT; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DOSE RESPONSE; DRUG ABUSE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; STEREOTYPY;

EID: 0029923893     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02143-4     Document Type: Article

References (38)

1. AbelbeckSoftware KaleidaGraph: Data analysis/graphics application. Reading, PA: Synergy Software; 1993.
2. Antelman, S. M.; Eichler, A. J.; Black, C. A.; Kocan, D. Interchangeability of stress and amphetamine in sensitization. Science 207:329-331; 1980.
3. Bailey, R. C.; Jackson, D. M. A pharmacological study of changes in central nervous system receptor responsiveness after long-term dextroamphetamine and apomorphine administration. Psychopharmacology (Berlin) 56:317-313; 1978.
4. Baker, L. E.; Riddle, E. E.; Saunders, R. B.; Appel, J. B. The role of monoamine uptake in the discriminative stimulus effects of cocaine. Behav. Pharmacol. 4:69-79; 1993.
5. Baldo, B. A.; Kelley, A. E. Cross-sensitization between cocaine and GBR12909, a dopamine uptake inhibitor. Brain Res. Bull. 27:105-108; 1991.
6. Barrett, R. L.; Appel, J. B. Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine. Psychopharmacology (Berlin) 99:13-16; 1989.
7. Baumann, M. H.; Char, G. U.; De Costa, B. R.; Rice, K. C.; Rothman, R. B. GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J. Pharmacol. Exp. Ther. 271:1216-1222; 1994.
8. Bergman, J.; Madras, B. K.; Johnson, S. E.; Spealman, R. D. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251:150-155; 1989.
9. Cline, E. J.; Terry, P.; Carroll, F. I.; Kuhar, M. J.; Katz, J. L. Stimulus generalization form cocaine to analogs with high in vitro affinity for dopamine-uptake sites. Behav. Pharmacol. 3:113-116; 1992.
10. Colpaert, F. C.; Niemegeers, C. J. E.; Janssen, P. A. J. Discriminative stimulus properties of cocaine: Neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol. Biochem. Behav. 10:535-546; 1979.
11. Comer, S. D.; France, C. P.; Woods, J. H. Training dose: Influences in opioid drug discrimination. In: Glennon, R. A.; Jarbe, T. U. C.; Frankenheim, J., eds. Drug discrimination: Applications to drug abuse research. Rockville, MD: DHHS Publication; 1991:145-162.
12. 10 dopamine region. Behav. Brain Res. 27:87-91; 1988.
13. Ellinwwood, E. H.; Balster, R. L. Rating the behavioral effects of amphetamine. Eur. J. Pharmacol. 27:34-41; 1974.
14. Elsworth, J. D.; Taylor, J. R.; Jatlow, P.; Roth, R. H. Serotonin involvement in cocaine sensitization: Clues from studies with cocaine analogs. Drug Dev. Res. 30:189-200; 1993.
15. Fray, P. J.; Sahakian, B. J.; Robbins, T. W.; Koob, G. F.; Iversen, S. D. An observational method for quantifying the behavioral effects of dopamine agonists: Contrasting effects of d-amphetamine and apomorphine. Psychopharmacology (Berlin) 69:253-259; 1980.
16. Glowa, J. R.; Wojnicki, F. H.; de Costa, B.; Matecka, D.; Rice, K. C.; Rothman, R. B. The effect of GBR12909 on responding of rhesus monkeys maintained under schedules of cocaine-and food-delivery. In: Harris, L. S., ed. NIDA Research Monograph. Washington, DC: NIH Publication; 1994:12.
17. Gorelick, D. A. Overview of pharmacological treatment approaches for alcohol and other drug addiction. Intoxication, withdrawal, and relapse. Psychiatr. Clin. North Am. 16:141-156; 1993.
18. Izenwasser, S.; Terry, P.; Heller, B.; Witkin, J. M.; Katz, J. L. Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors. Eur. J. Pharmacol. 263:277-283; 1994.
19. Kalivas, P. W.; Sorg, B. A.; Hooks, M. S. The pharmacology and neural circuitry of sensitization to psychomotor stimulants. Behav. Pharmacol. 4:315-335; 1993.
20. Kenakin, T. P. Pharmacologic analysis of drug-receptor interaction. New York: Raven Press; 1993.
21. Kilbey, M. M.; Ellinwood, E. H. Chronic administration of stimulant drugs: Response modification. In: Ellinwood, E. H.; Kilbey, M. M., eds. Cocaine and other stimulants. New York: Plenum Press; 1977:409-430.
22. Kleven, M. S.; Anthony, E. W.; Woolverton, W. L. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exper. Ther. 254:312-317; 1990.
23. Koek, W.; Woods, J. H. Partial generalization in pigeons trained to discriminate morphine from saline: Applications of receptor theory. Drug Dev. Res. 16:169-189; 1989.
24. Kosten, T. R. Current pharmacotherapies for opioid dependence. Psychopharmacol. Bull. 26:69-74; 1990.
25. Post, R. M.; Lockfeld, A.; Squillace, K. M.; Contel, N. R. Drug-environment interactions: Context dependency of cocaine-induced behavioral sensitization. Life Sci. 28:755-760; 1981.
26. Post, R. M.; Weiss, S. R. B. Sensitization and kindling: Implications for the evolution of psychiatric symptomatology. In: Kalivas, P.; Barnes, C. D., eds. Sensitization in the nervous system. Caldwell, NJ: Telford Press; 1988:257-291.
27. Post, R. M.; Weiss, S. R. B.; Pert, A. The role of context in conditioning and behavioral sensitization to cocaine. Psychopharmacol. Bull. 23:425-429; 1987.
28. Robinson, T. E.; Berridge, K. C. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res. Rev. 18:247-291; 1993.
29. 125]RTI-55. J. Pharmacol. Exp. Ther. 274:385-395; 1995.
30. Rothman, R. B.; Mele, A.; Reid, A. A.; Akunne, H. C.; Greig, N.; Thurkauf, A.; de Costa, B. R.; Rice, K. C.; Pert, A. GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol. Biochem. Behav. 40:387-397; 1991.
31. 123/125I]RTI-55, an in vivo label for the serotonin transporter. Synapse 11:134-139; 1992.
32. Stewart, J.; Vezina, P. Environment-specific enhancement of the hyperactivity induced by systemic or intra-VTA morphine injections in rats preexposed to amphetamine. Psychobiology 15:144-153; 1987.
33. Vezina, P.; Kalivas, P. W.; Stewart, J. Sensitization occurs to the locomotor efects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the VTA but not to the nucleus accumbens. Brain Res. 417:51-58; 1987.
34. Wise, R. A.; Leeb, K. Psychomotor-stimulant sensitization: A unitary phenomenon? Behav. Pharmacol. 4:339-350; 1993.
35. Witkin, J. M.; Nichols, D. E.; Terry, P.; Katz, J. L. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J. Pharmacol. Exp. Ther. 257:706-713; 1991.
36. Woods, J. H.; Winger, G. D.; France, C. P. Reinforcing and discriminative stimulus effects of cocaine. In: Fisher, S.; Raskin, A.; Uhlenhuth, E. H., eds. Cocaine: Biobehavioral aspects. New York: Oxford University Press; 1987:21-65.
37. Woolverton, W. L. Discriminative stimulus effects of cocaine. In: Glennon, R. A.; Jarbe, T. U. C.; Frankenheim, J., eds. NIDA Research Monograph. Washington, DC: U.S. Government Printing Office; 1991:61-74.
38. Zhang, L.; Barrett, J. E. Imipramine as a discriminative stimulus. J. Pharmacol. Exp. Ther. 259:1088-1093; 1991.